Exploring Medically Assisted Treatment Options for Addiction Recovery in Atlanta Outpatient Treatment Programs

In recent years, medically assisted treatment (MAT) has become a pivotal tool in the journey to addiction recovery, especially for individuals undergoing outpatient addiction treatment in Atlanta. MAT combines FDA-approved medications with counseling and behavioral therapies, significantly improving the chances of sustained recovery. Here, we’ll explore three popular injectable options — Sublocade, Vivitrol, and Brixadi — and their unique roles in early recovery and why their place in positive outcomes for some clients that qualify at Etowah Recovery Center and other Atlanta Outpatient treatment centers.

Sublocade: A Monthly Buprenorphine Injection for Opioid Dependence

Sublocade is an injectable form of buprenorphine, designed to release gradually over a month. This option is ideal for those dealing with opioid addiction, as it helps to alleviate cravings and withdrawal symptoms without requiring daily doses. Sublocade works by partially activating opioid receptors in the brain, reducing the risk of misuse and helping patients regain control over their lives. In IOP programs in Atlanta, Sublocade has become a preferred option due to its monthly administration, allowing individuals to maintain focus on recovery without the daily management of medications.

Vivitrol: An Opioid and Alcohol Relapse Prevention Tool

Vivitrol, or naltrexone, is a monthly injectable that blocks the brain’s opioid receptors, effectively preventing relapse by making it difficult to experience a “high” from opioids or alcohol. It’s especially helpful for individuals who have already detoxed and need a relapse-prevention tool as they rebuild their lives in outpatient settings. Many outpatient Atlanta addiction treatment centers incorporate Vivitrol into their MAT programs because it works effectively for both alcohol and opioid addiction recovery, helping to eliminate cravings and reduce the risk of returning to substance use.

Brixadi: The New Option in Buprenorphine-Based Treatment

Brixadi is a newer buprenorphine-based injectable treatment similar to Sublocade, but it offers more flexibility, with both weekly and monthly formulations. This adaptability allows patients and their treatment providers to customize a plan based on individual needs and progress. Brixadi’s extended-release formulation means patients can focus on therapy, support groups, and other aspects of their outpatient addiction treatment program in Atlanta without the constant need to manage cravings or withdrawal symptoms.

The Benefits of MAT in Outpatient Addiction Treatment Programs

Incorporating MAT options like Sublocade, Vivitrol, and Brixadi into intensive outpatient (IOP) programs in Atlanta offers many benefits. These injectables provide a safe and effective way to manage withdrawal symptoms and reduce cravings, allowing individuals to focus on recovery through counseling, support groups, and personal development. MAT helps to stabilize individuals in early recovery, making it easier for them to participate fully in outpatient programs and lay the foundation for long-term sobriety.

If you or a loved one are struggling with addiction, exploring the range of MAT options at Etowah Recovery Center. Our Outpatient Atlanta treatment center could be the significant step towards a brighter, healthier future.